(Q33774642)

29 July 2017

1 reference

title

Neurologic sequelae of treatment of primary CNS lymphomas (English)

1 reference

29 July 2017

Schlegel U

1

1 reference

29 July 2017

Pels H

series ordinal

2

1 reference

29 July 2017

Oehring R

series ordinal

3

1 reference

29 July 2017

Blümcke I

series ordinal

4

1 reference

29 July 2017

publication date

1 July 1999

1 reference

Journal of Neuro-Oncology

29 July 2017

published in

1 reference

29 July 2017

volume

43

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

277-286

1 reference

Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.

29 July 2017

cites work

1 reference

12 December 2020

Primary cerebral malignant non-Hodgkin's lymphomas: a retrospective clinical study

1 reference

12 December 2020

Progressive ascending paralysis following administration of intrathecal and intravenous cytosine arabinoside. A Pediatric Oncology Group study

1 reference

12 December 2020

Osteogenic sarcoma: MR signal abnormalities of the brain in asymptomatic patients treated with high-dose methotrexate.

1 reference

12 December 2020

Good performance status of long-term disease-free survivors of intracranial gliomas

1 reference

12 December 2020

Neurological complications of antineoplastic therapy

1 reference

12 December 2020

Primary central nervous system lymphoma: a role for adjuvant chemotherapy

1 reference

12 December 2020

Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome

1 reference

12 December 2020

Combined modality therapy for primary CNS lymphoma

1 reference

12 December 2020

Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma

1 reference

12 December 2020

Myelopathy after intrathecal chemotherapy. A case report with unique magnetic resonance imaging changes

1 reference

12 December 2020

High-dose methotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases

1 reference

12 December 2020

High dose Ara-C related leukoencephalopathy

1 reference

12 December 2020

Brain lesions following combined treatment with methotrexate and craniospinal irradiation

1 reference

12 December 2020

Combined therapy for primary central nervous system lymphoma in immunocompetent patients

1 reference

12 December 2020

Necrotizing Encephalopath Following Intraventricular Instillatio of Methotrexate

1 reference

12 December 2020

Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315

1 reference

12 December 2020

Primary malignant lymphoma of the brain. A report of 24 cases from the Norwegian Radium Hospital

1 reference

12 December 2020

Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results

1 reference

12 December 2020

Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study

1 reference

12 December 2020

Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy

1 reference

12 December 2020

Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients

1 reference

12 December 2020

Primary lymphoma of brain: results of management of a modern cohort with radiation therapy

1 reference

12 December 2020

Primary lymphoma of the central nervous system. An unresolved therapeutic problem

1 reference

12 December 2020

Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukemia of B-cell type

1 reference

12 December 2020

Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma. Trans-Tasman Radiation Oncology Group (TROG).

1 reference

12 December 2020

Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy.

1 reference

12 December 2020

Encephalopathy, myelopathy, optic neuropathy, and anosmia associated with intravenous cytosine arabinoside

1 reference

12 December 2020

Primary central nervous system lymphoma. Results at the University of California at Los Angeles and review of the literature.

1 reference

12 December 2020

Therapeutic irradiation and brain injury

1 reference

12 December 2020

Transient encephalopathy following a single exposure of high-dose methotrexate in a child with acute lymphoblastic leukemia

1 reference

12 December 2020

Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma

1 reference

12 December 2020

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia

1 reference

12 December 2020

Primary central nervous system lymphoma: treatment with chemotherapy and radiotherapy

1 reference

12 December 2020

Management of primary cerebral lymphoma with initial chemotherapy: Preliminary results and comparison with patients treated with radiotherapy alone

1 reference

12 December 2020

Biphasic patterns of memory deficits following moderate-dose partial-brain irradiation: neuropsychologic outcome and proposed mechanisms.

1 reference

12 December 2020

The therapy of primary brain lymphoma

1 reference

12 December 2020

Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters.

1 reference

12 December 2020

Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume

1 reference

12 December 2020

Transient encephalopathy during the late course of treatment with high-dose methotrexate

1 reference

12 December 2020

Effects of treatment on long-term survivors with malignant astrocytomas.

1 reference

12 December 2020

Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Ten years of treatment experience at the University of California San Francisco

1 reference

12 December 2020

Primary non-AIDS related brain lymphoma. Patterns of failure following radiotherapy

1 reference

12 December 2020

Subacute brain atrophy after radiation therapy for malignant brain tumor

1 reference

12 December 2020

Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006214804736

1 reference

Dimensions Publication ID

29 July 2017

1010981856

0 references

1 reference